3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
52
Leukemia, Myeloid, Acute
51
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Myeloproliferative Disorders
24
Lymphoma, Non-Hodgkin
19
Leukemia, Myelomonocytic, Chronic
15
Primary Myelofibrosis
12
Leukemia
11
Hodgkin Disease
11
Polycythemia Vera
9
Neuroblastoma
9
Histiocytosis, Langerhans-Cell
9
Glioma
9
Wilms Tumor
8
Sarcoma
8
Rhabdoid Tumor
8
Neuroectodermal Tumors, Primitive, Peripheral
8
Medulloblastoma
8
Hepatoblastoma
8
Ependymoma
8
Anemia, Refractory, with Excess of Blasts
8
Rhabdomyosarcoma
7
Osteosarcoma
7
Myelodysplastic-Myeloproliferative Diseases
7
Leukemia, Biphenotypic, Acute
7
Blast Crisis
7
Thrombocythemia, Essential
6
Multiple Myeloma
6
Blastic Plasmacytoid Dendritic Cell Neoplasm
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pyridoxine-dependent epilepsy
×
Myeloid
×
30 days
×
Clear all
No trials found.